• Recent Articles

  • Sodexo awarded for ethics as workers make minimum wage
  • Who owns your genes?
  • Apologies
  • The Robber Barons of Social Change
  • Good Intentions
  • Toyota’s Tylenol moment
  • “Walking away” not immoral, prof says
  • How Will the Citizens United Decision Affect Sustainable Business?
  • UK Business schools put ethics high on MBA agenda
  • Does Kraft’s Takeover Mean the End of Cadbury’s Fair Trade Policies?
  • U.S. Attorney: Johnson & Johnson Paid Millions In Kickbacks To Boost Sales Of Schizophrenia Drug In Nursing Homes
  • With Tylenol recall 2010, a corporate icon stumbles

• Archives

  Select Month May 2010 April 2010 March 2010 February 2010 January 2010 December 2009 November 2009 October 2009 September 2009 August 2009 July 2009 June 2009 May 2009 March 2009 February 2009 January 2009 December 2008 November 2008 October 2008 September 2008 August 2008 July 2008 April 2008 January 2008 December 2007 October 2007 September 2007 August 2007 July 2007 June 2007 April 2007 February 2007 May 2006 January 2006 April 2005 March 2005 February 2005 January 2005

Popular Tags for Articles

Academia Banks Bioethics Business Ethics Censorship Company Audit Statements Compensation Corporate Governance Corporate Personhood Corruption Economics Essays/Papers/Presentations Fair Trade Greenwashing International Investing Jeff Legislation Litigation Mortgages Obstructionists Pharmaceuticals Philanthrocapitalism Pledges Regulation Reports Scandals SEC Shame Stock Market Sustainability Sweatshops Transparency Wall Street

Article Tag: Pharmaceuticals

Not a good week for Johnson & Johnson, a company long considered by many to be a good example of corporate social responsibility. Earlier this week, the company expanded their recall of Tylenol and other products, but only after an FDA investigation revealed numerous problems that one of the company’s facilities. Now, the company is accused of paying kickbacks to nursing homes, in order to boost the use of a schizophrenia drug. Read the article here.

Excerpt:
TRENTON, N.J. — Federal prosecutors said Friday that health care giant Johnson & Johnson paid tens of millions of dollars in kickbacks so nursing homes would put more patients on its blockbuster schizophrenia medicine and other drugs.

In a complaint filed Friday, prosecutors said J&J paid rebates and other forms of kickbacks to Omnicare Inc., the country’s biggest dispenser of prescription drugs in nursing homes. Prosecutors allege Omnicare pharmacists then recommended that nursing home patients with signs of Alzheimer’s disease be put on the powerful schizophrenia drug Risperdal, which was later found to increase risk of death in the elderly.

The allegations are in a complaint filed by the U.S. Attorney in Boston, whose office has joined two whistle-blower cases. One was filed in 2003 by a former Omnicare pharmacist in Chicago, Bernard Lisitza, who alleges he was fired after he challenged the Risperdal kickbacks and other improper practices at the company. The other was filed by former Omnicare financial analyst David Kammerer in 2005, after he resigned from the company.

Read more… The New York Times also has an article here.

MSNBC.COM (Associated Press)
Read the article here.
Excerpt:

Analysis of a dozen published studies testing possible new uses for a Pfizer Inc. epilepsy drug found that reporting of the results was often misleading, indicating the medicine worked better than internal company documents showed.

According to the report, when a company-funded study’s primary finding wasn’t favorable, that result was usually buried and something else positive was highlighted, without disclosing the switch.

Read more…

• Search for:

• Articles/Posts

  Articles
  Resources
  Academic Sites
  Audits/Reports
  Company Statements/Principles
  Organizations
  Other Business Ethics Sites
  SR Investments
  SR Job Resources
  Sustainability
  Tools

• Article Tag Cloud

  Philanthrocapitalism Pledges Essays/Papers/Presentations Business Ethics Scandals International Corporate Personhood Shame Litigation Academia Corporate Governance Bioethics Economics Sweatshops Regulation Pharmaceuticals Investing Transparency Fair Trade Greenwashing SEC Company Audit Statements Mortgages Censorship Banks Jeff Reports Legislation Stock Market Sustainability Obstructionists Compensation Corruption Wall Street

• Twitter Posts